[조사자료] 글로벌 분자 세포 유전학 시장 (2023-2030) : 종양학, 맞춤 의학

■ 영문 제목 : Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV160 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 236 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오 테크놀로지

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 분자 세포 유전학 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 분자 세포 유전학 시장 규모는 2030년까지 44억 6000만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 CAGR 10. 6%로 성장할 것으로 전망됩니다. 임상병리 검사에서 분자 세포 유전학의 보급 증가, 표적 암 치료에 대한 관심 증가, 개인 맞춤형 의료에 대한 관심 증가가 성장을 촉진하는 주요 요인으로 꼽히고 있습니다. 또한, 유전성 질환의 발병률 증가, 분자 세포 유전학 분야의 기술 발전, 연구개발 활동의 활성화는 예측 기간 동안 시장 확대를 촉진할 것으로 예상됩니다.

또한, 하이스루풋 시퀀서의 통합으로 수행되는 세포유전학적 분석은 향후 몇 년 동안 성장을 크게 촉진할 것으로 예상되는 요인 중 하나입니다. 많은 과학자와 연구자들이 NGS와 세포유전학 연구소를 통합하고 있습니다. 따라서 시퀀싱 가격이 크게 하락함에 따라 시장은 상당한 속도로 성장할 것으로 추정됩니다.

코로나19의 유행은 분자 세포 유전학 시장에 긍정적인 영향을 미쳤습니다. 검사 우선순위가 바뀌면서 분자 세포 유전학 연구소는 코로나19 진단 검사로 방향을 전환했습니다. 또한 공중보건 유전체학에 대한 관심이 높아지면서 집단 기반 유전체 감시와 질병 확산 추적에 있어 분자 세포 유전학의 가치가 부각되어 효과적인 공중보건 전략 개발에 기여하고 있습니다. 이와 같이, 전염병 기간 동안 진단 검사의 높은 발생률은 분자 세포 유전학 시장의 성장을 촉진하고 있습니다.

다운 증후군, 지중해 빈혈, 낭포성 섬유증과 같은 유전성 질환의 발생률 증가는 예측 기간 동안 세그먼트의 성장을 촉진할 것으로 예상됩니다. 예를 들어, 세계보건기구(WHO)의 추정에 따르면, 1000명 중 약 10명이 유전성 질환을 앓고 있으며, 이는 전 세계적으로 약 7000만~8000만 명에 해당합니다. 또한, 세포유전학 도구의 기술적 진보에 대한 사업자들의 전략적 이니셔티브가 증가함에 따라 분자 세포유전학 시장을 촉진할 것으로 예측됩니다. 예를 들어, 2022년 10월 Genoox는 Thermo Fisher Scientific과 제휴하여 CytoScan Automated Interpretation and Reporting (AIR) 솔루션을 발표했습니다. 이 도구는 세포유전학 연구 데이터 분석을 용이하게 해줄 것으로 기대됩니다.

분자 세포 유전학 시장 보고서 주요 내용

- 용도별로는 암 분야가 2022년 39. 70%의 점유율로 시장을 주도했습니다. 이는 CGH 기술이 암의 병인에 대한 심층적인 연구를 가능하게 하기 때문입니다.

- 제품별로는 유전성 질환과 맞춤의료에 대한 지식과 인식이 높아짐에 따라 소모품이 2022년 39. 51%의 점유율을 차지했습니다.

- 기술별로는 더 나은 염색체 분석을 위한 기술 발전의 증가로 인해 비교 게놈 하이브리드화 분야가 2022년 분자 세포 유전학 시장을 지배할 것으로 예상됩니다.

- 최종 용도별로는 임상 및 연구 검사 부문이 2022년 매출 점유율의 대부분을 차지했습니다. 반면, 제약 및 생명 공학 기업 부문은 예측 기간 동안 가장 빠른 CAGR을 보일 것으로 예상됩니다.

- 2022년 북미는 기술 발전, 의료 인프라 개선, 주요 기업의 존재, 이 지역의 의약품 임상 시험 및 승인 건수 증가로 인해 북미가 업계를 지배할 것으로 보인다고 전했습니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변동, 동향, 범위
Chapter 4. 세계의 분자 세포 유전학 시장 : 용도별 예측 및 동향 분석
Chapter 5. 세계의 분자 세포 유전학 시장 : 기술별 예측 및 동향 분석
Chapter 6. 세계의 분자 세포 유전학 시장 : 제품별 예측 및 동향 분석
Chapter 7. 세계의 분자 세포 유전학 시장 : 최종 용도별 예측 및 동향 분석
Chapter 8. 세계의 분자 세포 유전학 시장 : 지역별 예측 및 동향 분석
Chapter 9. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1 Molecular Cytogenetics Market: Research Methodology And Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Application Segment
1.1.1.2 Technology Segment
1.1.1.3 Product Segment
1.1.1.4 End Use Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2 Molecular Cytogenetics Market: Executive Summary
2.1 Market Outlook
2.2 Application And Technology Snapshot
2.3 Product And End Use Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Molecular Cytogenetics Market: Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Rapid technological advancements
3.2.1.2 Increasing prevalence of genetic disorders
3.2.1.3 Growing application in oncology
3.2.1.4 Increasing demand for personalized medicine
3.2.2 Market Restraint Analysis
3.2.2.1 High Costs Of Testing
3.2.2.2 Lack Of Reimbursement Policies
3.3 Industry Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel Analysis
Chapter 4 Molecular Cytogenetics Market: Application Business Analysis
4.1 Molecular Cytogenetics Market: Application Movement Analysis
4.2 Genetic Disorders
4.2.1 Genetic Disorders Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Oncology
4.3.1 Oncology Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Personalized Medicine
4.4.1 Personalized Medicine Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.5 Other Application
4.5.1 Other Application Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Molecular Cytogenetics Market: Technology Business Analysis
5.1 Molecular Cytogenetics Market: Technology Movement Analysis
5.2 Comparative Genomic Hybridisation
5.2.1 Comparative Genomic Hybridisation Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.2 ACGH
5.2.2.1 ACGH Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.3 SCGH
5.2.3.1 SCGH Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Fish
5.3.1 Fish Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Immunohistochemistry
5.4.1 Immunohistochemistry Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.5 Karyotyping
5.5.1 Karyotyping Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.5.2 Spectral
5.5.2.1 Spectral Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.5.3 Virtual
5.5.3.1 Virtual Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.6 Others
5.6.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Molecular Cytogenetics Market: Product Business Analysis
6.1 Molecular Cytogenetics Market: Product Movement Analysis
6.2 Instruments
6.2.1 Instruments Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Consumables
6.3.1 Consumables Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Software & Services
6.4.1 Software & Services Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Molecular Cytogenetics Market: End Use Business Analysis
7.1 Molecular Cytogenetics Market: End Use Movement Analysis
7.2 Clinical & Research Laboratories
7.2.1 Clinical & Research Laboratories Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.3 Hospitals & Path Labs
7.3.1 Hospitals & Path Labs Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4 Academic Research Institutes
7.4.1 Academic Research Institutes Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.5 Pharmaceutical & Biotech Companies
7.5.1 Pharmaceutical & Biotech Companies Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.6 Others
7.6.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 Molecular Cytogenetics Market: Regional Business Analysis
8.1 Regional Market Snapshot
8.2 North America
8.2.1 North America Molecular Cytogenetics Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.2.2.2 Key Country Dynamics
8.2.2.3 Regulatory Framework
8.2.2.4 Reimbursement Scenario
8.2.3 Canada
8.2.3.1 Canada Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.2.3.2 Key Country Dynamics
8.2.3.3 Regulatory Framework
8.2.3.4 Reimbursement Scenario
8.3 Europe
8.3.1 Europe Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.2 UK
8.3.2.1 UK Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.2.2 Key Country Dynamics
8.3.2.3 Regulatory Framework
8.3.2.4 Reimbursement Scenario
8.3.3 Germany
8.3.3.1 Germany Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.3.2 Key Country Dynamics
8.3.3.3 Regulatory Framework
8.3.3.4 Reimbursement Scenario
8.3.4 Spain
8.3.4.1 Spain Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.4.2 Key Country Dynamics
8.3.4.3 Regulatory Framework
8.3.4.4 Reimbursement Scenario
8.3.5 France
8.3.5.1 France Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.5.2 Key Country Dynamics
8.3.5.3 Regulatory Framework
8.3.5.4 Reimbursement Scenario
8.3.6 Italy
8.3.6.1 Italy Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.6.2 Key Country Dynamics
8.3.6.3 Regulatory Framework
8.3.6.4 Reimbursement Scenario
8.3.7 Denmark
8.3.7.1 Denmark Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.7.2 Key Country Dynamics
8.3.7.3 Regulatory Framework
8.3.7.4 Reimbursement Scenario
8.3.8 Sweden
8.3.8.1 Sweden Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.8.2 Key Country Dynamics
8.3.8.3 Regulatory Framework
8.3.8.4 Reimbursement Scenario
8.3.9 Norway
8.3.9.1 Norway Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.3.9.2 Key Country Dynamics
8.3.9.3 Regulatory Framework
8.3.9.4 Reimbursement Scenario
8.4 Asia Pacific
8.4.1 Asia-Pacific Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.4.2.2 Key Country Dynamics
8.4.2.3 Regulatory Framework
8.4.2.4 Reimbursement Scenario
8.4.3 China
8.4.3.1 China Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.4.3.2 Key Country Dynamics
8.4.3.3 Regulatory Framework
8.4.3.4 Reimbursement Scenario
8.4.4 India
8.4.4.1 India Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.4.4.2 Key Country Dynamics
8.4.4.3 Regulatory Framework
8.4.4.4 Reimbursement Scenario
8.4.5 South Korea
8.4.5.1 South Korea Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.4.5.2 Key Country Dynamics
8.4.5.3 Regulatory Framework
8.4.5.4 Reimbursement Scenario
8.4.6 Thailand
8.4.6.1 Thailand Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.4.6.2 Key Country Dynamics
8.4.6.3 Regulatory Framework
8.4.6.4 Reimbursement Scenario
8.4.7 Australia
8.4.7.1 Australia Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.4.7.2 Key Country Dynamics
8.4.7.3 Regulatory Framework
8.4.7.4 Reimbursement Scenario
8.5 Latin America
8.5.1 Latin America Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.5.2.2 Key Country Dynamics
8.5.2.3 Regulatory Framework
8.5.2.4 Reimbursement Scenario
8.5.3 Mexico
8.5.3.1 Mexico Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.5.3.2 Key Country Dynamics
8.5.3.3 Regulatory Framework
8.5.2.4 Reimbursement Scenario
8.5.4 Argentina
8.5.4.1 Argentina Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.5.4.2 Key Country Dynamics
8.5.4.3 Regulatory Framework
8.5.4.4 Reimbursement Scenario
8.6 MEA
8.6.1 MEA Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.6.2.2 Key Country Dynamics
8.6.2.3 Regulatory Framework
8.6.2.4 Reimbursement Scenario
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.6.3.2 Key Country Dynamics
8.6.3.3 Regulatory Framework
8.6.3.4 Reimbursement Scenario
8.6.4 UAE
8.6.4.1 UAE Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.6.4.2 Key Country Dynamics
8.6.4.3 Regulatory Framework
8.6.2.4 Reimbursement Scenario
8.6.5 Kuwait
8.6.5.1 Kuwait Molecular Cytogenetics Market, 2018 – 2030 (USD Million)
8.6.5.2 Key Country Dynamics
8.6.5.3 Regulatory Framework
8.6.5.4 Reimbursement Scenario
Chapter 9 Molecular Cytogenetics Market: Competitive Landscape
9.1 Company Categorization
9.2 Strategy Mapping
9.2.1 New product launch
9.2.2 Partnerships
9.2.3 Acquisition
9.2.4 Collaboration
9.2.5 Funding
9.3 Company Market Share Analysis, 2022
9.4 Company Profiles
9.4.1 BIOVIEW
9.4.1.1 Company overview
9.4.1.2 Financial performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic initiatives
9.4.2 DANAHER
9.4.2.1 Company overview
9.4.2.1.1 Leica Biosystems Nussloch GmbH
9.4.2.2 Financial performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.3 METASYSTEMS
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic initiatives
9.4.4 AGILENT TECHNOLOGIES, INC.
9.4.4.1 Company overview
9.4.4.2 Financial performance
9.4.4.3 Product benchmarking
9.4.4.4 Strategic initiatives
9.4.5 ABBOTT
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic initiatives
9.4.6 BIO-RAD LABORATORIES, INC.
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic initiatives
9.4.7 ILLUMINA, INC.
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.8 OXFORD GENE TECHNOLOGY
9.4.8.1 Company overview
9.4.8.2 Financial performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic initiatives
9.4.9 F. HOFFMANN-LA ROCHE LTD
9.4.9.1 Company overview
9.4.9.1.1 Genentech, Inc.
9.4.9.2 Financial performance
9.4.9.4 Product benchmarking
9.4.9.5 Strategic initiatives
9.4.10 PERKINELMER INC.
9.4.10.1 Company overview
9.4.10.2 Financial performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic initiatives
9.4.11 QUEST DIAGNOSTICS INCORPORATED
9.4.11.1 Company overview
9.4.11.1.1 Sonora Quest Laboratories
9.4.11.2 Financial performance
9.4.11.3 Product benchmarking
9.4.11.4 Product benchmarking
9.4.11.5 Strategic initiatives
9.4.12 APPLIED SPECTRAL IMAGING
9.4.12.1 Company overview
9.4.12.2 Financial performance
9.4.12.3 Product benchmarking
9.4.12.4 Strategic initiatives
9.4.13 BIOLOGICAL INDUSTRIES USA, INC.
9.4.13.1 Company overview
9.4.13.2 Financial performance
9.4.13.3 Product benchmarking
9.4.13.4 Strategic initiatives
9.4.14 CYTOTEST
9.4.14.1 Company overview
9.4.14.2 Financial performance
9.4.14.3 Product benchmarking
9.4.14.4 Strategic initiatives
9.4.15 CYTOGNOMIX
9.4.15.1 Company overview
9.4.15.2 Financial performance
9.4.15.3 Product benchmarking
9.4.16 GENIAL GENETICS
9.4.16.1 Company overview
9.4.16.2 Financial performance
9.4.16.3 Product benchmarking
9.4.16.4 Strategic initiatives
9.4.17 DIAGNOSTIC CYTOGENETICS, INC. (DCI)
8.4.17.1 Company overview
8.4.17.2 Financial performance
8.4.17.3 Product benchmarking
Chapter 10 KOL Recommendations/Analyst Perspective

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
Table 4. North America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 5. North America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 6. North America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 7. North America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 8. U.S. molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 9. U.S. molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 10. U.S. molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 11. U.S. molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 12. Canada molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 13. Canada molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 14. Canada molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 15. Canada molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 16. Europe molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
Table 17. Europe molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 18. Europe molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 19. Europe molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 20. Europe molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 21. UK molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 22. UK molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 23. UK molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 24. UK molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 25. Germany molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 26. Germany molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 27. Germany molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 28. Germany molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 29. France molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 30. France molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 31. France molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 32. France molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 33. Italy molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 34. Italy molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 35. Italy molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 36. Italy molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 37. Spain molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 38. Spain molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 39. Spain molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 40. Spain molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 41. Denmark molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 42. Denmark molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 43. Denmark molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 44. Denmark molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 45. Sweden molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 46. Sweden molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 47. Sweden molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 48. Sweden molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 49. Norway molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 50. Norway molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 51. Norway molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 52. Norway molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 53. Asia Pacific molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
Table 54. Asia Pacific molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 55. Asia Pacific molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 56. Asia Pacific molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 57. Asia Pacific molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 58. China molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 59. China molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 60. China molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 61. China molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 62. Japan molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 63. Japan molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 64. Japan molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 65. Japan molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 66. South Korea molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 67. South Korea molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 68. South Korea molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 69. South Korea molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 70. Australia molecular cytogenetics market, by application 2018 - 2030 (USD Million)
Table 71. Australia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 72. Australia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 73. Australia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 74. Thailand molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 75. Thailand molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 76. Thailand molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 77. Thailand molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 78. India molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 79. India molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 80 India molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 81. India molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 82. Latin America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
Table 83. Latin America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 84. Latin America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 85. Latin America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 86. Latin America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 87. Brazil molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 88. Brazil molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 89. Brazil molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 90. Brazil molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 91. Mexico molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 92. Mexico molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 93. Mexico molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 94. Mexico molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 95. Argentina molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 96. Argentina molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 97. Argentina molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 98. Argentina molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 99. Middle East & Africa molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
Table 100. Middle East & Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 101. Middle East & Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 102. Middle East & Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 103. Middle East & Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 104. South Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 105. South Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 106. South Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 107. South Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 108. Saudi Arabia molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 109. Saudi Arabia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 110. Saudi Arabia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 111. Saudi Arabia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 112. UAE molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 113. UAE molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 114. UAE molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 115. UAE molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
Table 116. Kuwait molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
Table 117. Kuwait molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
Table 118. Kuwait molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
Table 119. Kuwait molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)

※본 조사보고서 [글로벌 분자 세포 유전학 시장 (2023-2030) : 종양학, 맞춤 의학] (코드 : GRV23NOV160) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 분자 세포 유전학 시장 (2023-2030) : 종양학, 맞춤 의학] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

글로벌 바이오 의약품 첨가제 시장 (2023-2030) : 폴리올, 가용화제 및 계면활성제/유화제, 탄수화물, 특수 부형제
GRV23NOV054 / Grand View Research / 2023년 9월 / 글로벌 바이오 의약품 첨가제 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 바이오 의약품 첨가제 시장 규모는 2030년까지 37. 6억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 5....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수, 동향 및 범위 Chapter 4. 세계의 바이오 의약품 첨가제 시장 : 제품별 분석 Chapter 5. 세계의 바이오 의약품 첨가제 시장 : 지역별 분석 Chapter 6. 세계의 바이오 의약품 첨가제 시장 : 경쟁 현황 Chapter 7. KOL 권고사항/애널리스트...

글로벌 펩티드 약물 복합체 시장 (2023-2030) : 루테튬, 멜플루펜, ANG1005, BT1718, CBX-12, 기타 파이프 라인
GRV23NOV280 / Grand View Research / 2023년 9월 / 글로벌 펩타이드 약물 복합체 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 펩타이드 약물 복합체 시장은 2030년까지 42억 1000만 달러에 달할 것으로 예상되며, 예측 기간 동안 28. 58%의...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 펩티드 약물 복합체 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 펩티드 약물 복합체 시장 : 제품별 예측 및 동향 분석 Chapter 6. 세계의 펩티드 약물 복합체 시장 : 지역별...

글로벌 카르바페넴 시장 (2023-2030) : 메로펜, 이미페넴, 에르타페넴
GRV23NOV065 / Grand View Research / 2023년 9월 / 글로벌 카르바페넴 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 카르바페넴 시장 규모는 2030년까지 52. 4억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 4. 78%의 성장률을 기록할 것으로...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수, 동향 및 범위 Chapter 4. 세계의 카르바페넴 시장 : 약품 종류별 예측 및 동향 분석 Chapter 5. 세계의 카르바페넴 시장 : 용도별 예측 및 동향 분석 Chapter 6. 세계의 카르바페넴 시장 : 유통 채널별 예측 및 동향...

글로벌 암 생검 시장 (2023-2030) : 액체 생검, 코어 바늘 생검
GRV23NOV061 / Grand View Research / 2023년 9월 / 글로벌 암 생검 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 암 생검 시장 규모는 2030년까지 연평균 8. 04% 성장하여 516. 1억 달러에 달할 것으로 추정됩니다. 분자 의학의...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 암 생검 시장 변수, 동향 및 범위 Chapter 4. 세계의 암 생검 시장 : 제품별 분석 Chapter 5. 세계의 암 생검 시장 : 유형별 분석 Chapter 6. 세계의 암 생검 시장 : 용도별 분석 Chapter 7. 세계의 암...

글로벌 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 (2023-2030) : Flow FISH, Q FISH
GRV23NOV118 / Grand View Research / 2023년 9월 / 글로벌 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장의 성장 및 동향 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 규모는 예측 기간 동안 7. 6%의 CAGR을 기록하며 2030년까지 14. 9억...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 변수/동향/범위 Chapter 4. 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 : 기술별 예측 및 동향 분석 Chapter 5. 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 : 유형별 예측 및...